TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
MedPharm Consult AB
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
485
|
99
|
329 |
Financial expenses |
1
![]() |
1
|
0 |
Earnings before taxes |
228
|
51
|
161 |
EBITDA |
229
|
53
|
161 |
Total assets |
470
|
158
|
342 |
Current assets |
465
|
152
|
339 |
Current liabilities |
180
|
49
|
122 |
Equity capital |
281
|
100
|
211 |
- share capital |
34
|
33
|
36 |
Employees (average) |
2
|
0
|
1 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
59.8%
|
63.3%
|
61.7% |
Turnover per employee | 242 | 329 | |
Profit as a percentage of turnover |
47.0%
|
51.5%
|
48.9% |
Return on assets (ROA) |
48.7%
|
32.9%
|
47.1% |
Current ratio |
258.3%
|
310.2%
|
277.9% |
Return on equity (ROE) |
81.1%
|
51.0%
|
76.3% |
Change turnover |
386
|
-204
|
329 |
Change turnover % |
388%
|
-67% | |
Chg. No. of employees |
2
|
-1
|
1 |
Chg. No. of employees % | -100% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.